Beringea Growth Finance has realised an ‘attractive’ return following the acquisition of Speciality European Pharma (SEP) by life science investor Juno Pharmaceuticals. In December 2014 Beringea Growth Finance agreed a GBP4.7m 4-year term loan to SEP. Beringea Growth Finance is part of Beringea, the transatlantic investor in high growth businesses

NorthEdge Capital, a private equity firm focussed on the North of England, has provided a multi million pound injection of development capital into the company behind premium casual dining brands Neighbourhood and Victor’s. East Coast Concepts, which was founded by entrepreneur James Hitchen and his brother Guy, currently operates the

Union Oil and Gas Group (UOGG), a subsidiary of private equity firm Union Group, and state corporation Empresa Nicaraguense del Petróleo (‘PETRONIC), are to sign an agreement for future operations in four oil and gas blocks in the Sandino Basin offshore of Nicaragua. The agreement, which is currently being finalised

A Coventry-based manufacturer that provides specialist modification to vehicles in the automotive, aerospace, defence and rail sectors has received a GBP1million investment. Penso City Vehicles will use the funding to invest in tools to modify the Mercedes Vito Tourer into a low emission taxi, including improving its turning circle and

Union Oil and Gas Group (UOGG), a subsidiary of private equity firm Union Group, and state corporation Empresa Nicaraguense del Petróleo (‘PETRONIC), are to sign an agreement for future operations in four oil and gas blocks in the Sandino Basin offshore of Nicaragua. The agreement, which is currently being finalised

Law firm Howard Kennedy is advising Lebanese restaurant chain Comptoir Group on its AIM listing, raising some GBP16 million. Comptoir Group currently operates 11 Comptoir Libanais restaurants, together with further franchise outlets.  It also operates two smaller Lebanese and Eastern Mediterranean outlets under the Shawa brand, and a further two

Biopharmaceutical company IFM Therapeutics has closed a USD27 million Series A financing led by Atlas Venture and Abingworth, with participation from Novartis.  In conjunction with the funding Jean-François Formela and Vincent Miles, Partners at Atlas and Abingworth respectively, have joined IFM’s CEO, Gary D. Glick, on the board of directors,

PwC's new Global 100 Software Leaders ranking illustrates a rapidly shifting landscape and reveals three key trends among companies that are taking advantage of both evolutionary and revolutionary changes in the software industry. Within this shifting environment, the interwoven trends of digital innovation, Industry 4.0 and convergence are driving opportunities

IFM Therapeutics, a biopharmaceutical company developing a portfolio of small molecules targeting the innate immune system, has closed a USD27 million Series A financing led by Atlas Venture and Abingworth, with participation from Novartis.  In conjunction with the funding Jean-François Formela and Vincent Miles, Partners at Atlas and Abingworth respectively,